Cardiology

RDT unveils a new approach to monitoring defibrillation

Remote Diagnostic Technologies Ltd (RDT) previewed its Tempus ALS™ monitor defibrillator at MEDICA 2016, ahead of its official launch in early 2017. Tempus ALS offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package.

The Tempus ALS combines a defibrillator and advanced life support monitoring in...
The Tempus ALS combines a defibrillator and advanced life support monitoring in a compact package, enabling pre-hospital medics to carry less and work more efficiently.
Source: Remote Diagnostic Technologies

Tempus ALS delivers a new, cutting-edge approach to monitoring defibrillation and provides unparalleled choice on how pre-hospital equipment is deployed and operated. The advanced monitor provides a 12-Lead ECG, configurable STEMI reporting and capnography, with over 10 hours of battery life. It also provides access to advanced features such as video laryngoscopy, point of injury ultrasound, patient reports and real-time telemedicine.

The defibrillator is lighter and smaller than most AEDs, but with manual defibrillation, AED, synchronous cardioversion, pacing, CPR feedback and a 4-Lead ECG. Its small battery is capable of delivering up to 300 shocks with typically four to five hours of monitoring. Because it is small and light enough to always be carried to scene, it also means code review is always available for every incident.
 
Tempus ALS’s market-leading data collection and connectivity also offer significant benefits for patient management. Its unique patient Summary Record of Care™ (SRoC™) provides automated recording of all vital sign data, defibrillation and CPR therapies, event capture video and photographic images. The data can then be quickly and easily shared in a number of ways including monitor-to-monitor transfer, transfer via USB, email or directly into the hospital’s own ePCR, ensuring that therapy data is always available for follow-up patient care.

The flow of data is further enhanced by the advanced monitor’s ReachBak™ telemedicine capability. This feature offers real-time data streaming, enabling emergency departments to assess and plan a patient’s care before they even arrive. For example, pre-hospital STEMI or MI patients can be transferred directly from the ambulance to the cath lab, saving precious door to needle time. Backed by over 20 years of RDT service and support expertise, this all adds up to pre-hospital medics carrying less, doing more and working smarter.

To learn more about the Tempus ALS, go to www.tempusals.com


Source: Remote Diagnostic Technologies

14.12.2016

More on the subject:
Read all latest stories

Related articles

Photo

Pioneering cardiology

Implantable cardiac monitor gets diagnosis in just three days

It started as a fairly typical case: The 79-year-old patient had suffered unexplained dizziness for years. To diagnose why, the cardiology team at Sweden’s Kalmar Hospital performed…

Photo

Biomonitor III

The next generation injectable cardiac monitor

Biotronik announces the market release of its new injectable cardiac monitor (ICM), Biomonitor III, following approval in the CE region. The novel device is designed to help patients with irregular…

Photo

Cardiology

White Coat Hypertension: Untreated increases risk of dying

People with untreated White Coat Hypertension are twice as likely to die from heart disease. Researchers at Penn Medicine say findings underscore the need for increased out-of-office blood pressure…

Related products